Impact of REAC Regenerative Endogenous Bioelectrical Cell Reprogramming on MCF7 Breast Cancer Cells
Human breast adenocarcinoma is a form of cancer which has the tendency to metastasize to other tissues, including bones, lungs, brain, and liver. Several chemotherapeutic drugs are used to treat breast tumors. Their combination is used to simultaneously target different mechanisms involved in cell r...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-06-01
|
| Series: | Journal of Personalized Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4426/13/6/1019 |
| _version_ | 1797593963402625024 |
|---|---|
| author | Vania Fontani Sara Cruciani Sara Santaniello Salvatore Rinaldi Margherita Maioli |
| author_facet | Vania Fontani Sara Cruciani Sara Santaniello Salvatore Rinaldi Margherita Maioli |
| author_sort | Vania Fontani |
| collection | DOAJ |
| description | Human breast adenocarcinoma is a form of cancer which has the tendency to metastasize to other tissues, including bones, lungs, brain, and liver. Several chemotherapeutic drugs are used to treat breast tumors. Their combination is used to simultaneously target different mechanisms involved in cell replication. Radio electric asymmetric conveyer (REAC) technology is an innovative technology, used both in vitro and in vivo, to induce cell reprogramming and counteract senescence processes. Within this context, we treated MCF-7 cells with a regenerative (RGN) REAC treatment for a period ranging between 3 and 7 days. We then analyzed cell viability by trypan blue assays and gene and protein expression by real time-qPCR and confocal microscope, respectively. We also detected the levels of the main proteins involved in tumor progression, DKK1 and SFRP1, by ELISA and cell senescence by β-galactosidase tests. Our results showed the ability of REAC RGN to counteract MCF-7 proliferation, probably inducing autophagy via the upregulation of Beclin-1 and LC3-I, and the modulation of specific tumorigenic biomarkers, such as DKK1 and SPFR1. Our results could suggest the application of the REAC RGN in future in vivo experiments, as an aid for the therapeutic strategies usually applied for breast cancer treatment. |
| first_indexed | 2024-03-11T02:16:00Z |
| format | Article |
| id | doaj.art-fc3e6cbcb7ca4c5283367f329404a5ab |
| institution | Directory Open Access Journal |
| issn | 2075-4426 |
| language | English |
| last_indexed | 2024-03-11T02:16:00Z |
| publishDate | 2023-06-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Personalized Medicine |
| spelling | doaj.art-fc3e6cbcb7ca4c5283367f329404a5ab2023-11-18T11:12:00ZengMDPI AGJournal of Personalized Medicine2075-44262023-06-01136101910.3390/jpm13061019Impact of REAC Regenerative Endogenous Bioelectrical Cell Reprogramming on MCF7 Breast Cancer CellsVania Fontani0Sara Cruciani1Sara Santaniello2Salvatore Rinaldi3Margherita Maioli4Department of Regenerative Medicine, Rinaldi Fontani Institute, 50144 Florence, ItalyResearch Department, Rinaldi Fontani Foundation, 50144 Florence, ItalyResearch Department, Rinaldi Fontani Foundation, 50144 Florence, ItalyDepartment of Regenerative Medicine, Rinaldi Fontani Institute, 50144 Florence, ItalyResearch Department, Rinaldi Fontani Foundation, 50144 Florence, ItalyHuman breast adenocarcinoma is a form of cancer which has the tendency to metastasize to other tissues, including bones, lungs, brain, and liver. Several chemotherapeutic drugs are used to treat breast tumors. Their combination is used to simultaneously target different mechanisms involved in cell replication. Radio electric asymmetric conveyer (REAC) technology is an innovative technology, used both in vitro and in vivo, to induce cell reprogramming and counteract senescence processes. Within this context, we treated MCF-7 cells with a regenerative (RGN) REAC treatment for a period ranging between 3 and 7 days. We then analyzed cell viability by trypan blue assays and gene and protein expression by real time-qPCR and confocal microscope, respectively. We also detected the levels of the main proteins involved in tumor progression, DKK1 and SFRP1, by ELISA and cell senescence by β-galactosidase tests. Our results showed the ability of REAC RGN to counteract MCF-7 proliferation, probably inducing autophagy via the upregulation of Beclin-1 and LC3-I, and the modulation of specific tumorigenic biomarkers, such as DKK1 and SPFR1. Our results could suggest the application of the REAC RGN in future in vivo experiments, as an aid for the therapeutic strategies usually applied for breast cancer treatment.https://www.mdpi.com/2075-4426/13/6/1019MCF7cell proliferationcellular mechanismssenescencebreast adenocarcinomaendogenous bioelectric activity |
| spellingShingle | Vania Fontani Sara Cruciani Sara Santaniello Salvatore Rinaldi Margherita Maioli Impact of REAC Regenerative Endogenous Bioelectrical Cell Reprogramming on MCF7 Breast Cancer Cells Journal of Personalized Medicine MCF7 cell proliferation cellular mechanisms senescence breast adenocarcinoma endogenous bioelectric activity |
| title | Impact of REAC Regenerative Endogenous Bioelectrical Cell Reprogramming on MCF7 Breast Cancer Cells |
| title_full | Impact of REAC Regenerative Endogenous Bioelectrical Cell Reprogramming on MCF7 Breast Cancer Cells |
| title_fullStr | Impact of REAC Regenerative Endogenous Bioelectrical Cell Reprogramming on MCF7 Breast Cancer Cells |
| title_full_unstemmed | Impact of REAC Regenerative Endogenous Bioelectrical Cell Reprogramming on MCF7 Breast Cancer Cells |
| title_short | Impact of REAC Regenerative Endogenous Bioelectrical Cell Reprogramming on MCF7 Breast Cancer Cells |
| title_sort | impact of reac regenerative endogenous bioelectrical cell reprogramming on mcf7 breast cancer cells |
| topic | MCF7 cell proliferation cellular mechanisms senescence breast adenocarcinoma endogenous bioelectric activity |
| url | https://www.mdpi.com/2075-4426/13/6/1019 |
| work_keys_str_mv | AT vaniafontani impactofreacregenerativeendogenousbioelectricalcellreprogrammingonmcf7breastcancercells AT saracruciani impactofreacregenerativeendogenousbioelectricalcellreprogrammingonmcf7breastcancercells AT sarasantaniello impactofreacregenerativeendogenousbioelectricalcellreprogrammingonmcf7breastcancercells AT salvatorerinaldi impactofreacregenerativeendogenousbioelectricalcellreprogrammingonmcf7breastcancercells AT margheritamaioli impactofreacregenerativeendogenousbioelectricalcellreprogrammingonmcf7breastcancercells |